LV12129B - 3-metilpiperidīna un 3-metilpiridīna iegūšanas metode, katalītiski ciklizējot 2-metil-1,5-diaminopentānu - Google Patents

3-metilpiperidīna un 3-metilpiridīna iegūšanas metode, katalītiski ciklizējot 2-metil-1,5-diaminopentānu Download PDF

Info

Publication number: LV12129B
Authority: LV; Latvia
Prior art keywords: von; der; die; methyl; beispiel
Prior art date: 1993-04-02

Application number

LVP-98-124A

Other languages

English (en)

Latvian (lv)

Other versions

LV12129A (lv

Inventor

Josef Heveling

Erich Armbruster

Walter Siegrist

Original Assignee

Lonza Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-02

Filing date

1998-05-28

Publication date

1998-12-20

1994-01-06 Priority claimed from CH3794A external-priority patent/CH686135A5/de

1998-05-28 Application filed by Lonza Ag filed Critical Lonza Ag

1998-09-20 Publication of LV12129A publication Critical patent/LV12129A/xx

1998-12-20 Publication of LV12129B publication Critical patent/LV12129B/lv

Links

ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 title claims abstract description 29
JZUHIOJYCPIVLQ-UHFFFAOYSA-N 2-methylpentane-1,5-diamine Chemical compound NCC(C)CCCN JZUHIOJYCPIVLQ-UHFFFAOYSA-N 0.000 title claims abstract description 18
JEGMWWXJUXDNJN-UHFFFAOYSA-N 3-methylpiperidine Chemical compound CC1CCCNC1 JEGMWWXJUXDNJN-UHFFFAOYSA-N 0.000 title claims abstract description 15
238000000034 method Methods 0.000 title claims description 8
239000003054 catalyst Substances 0.000 claims abstract description 23
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 62
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 28
229910052763 palladium Inorganic materials 0.000 claims description 27
229910052593 corundum Inorganic materials 0.000 claims description 12
229910001845 yogo sapphire Inorganic materials 0.000 claims description 12
HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 8
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 7
YAIQCYZCSGLAAN-UHFFFAOYSA-N [Si+4].[O-2].[Al+3] Chemical compound [Si+4].[O-2].[Al+3] YAIQCYZCSGLAAN-UHFFFAOYSA-N 0.000 claims description 3
229910052697 platinum Inorganic materials 0.000 claims description 2
238000006356 dehydrogenation reaction Methods 0.000 claims 4
239000010970 precious metal Substances 0.000 claims 2
229910021536 Zeolite Inorganic materials 0.000 claims 1
230000002378 acidificating effect Effects 0.000 claims 1
238000005342 ion exchange Methods 0.000 claims 1
239000010457 zeolite Substances 0.000 claims 1
239000007792 gaseous phase Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 34
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 21
239000000243 solution Substances 0.000 description 21
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
229910052681 coesite Inorganic materials 0.000 description 18
229910052906 cristobalite Inorganic materials 0.000 description 18
229910052682 stishovite Inorganic materials 0.000 description 18
229910052905 tridymite Inorganic materials 0.000 description 18
239000000377 silicon dioxide Substances 0.000 description 14
238000006243 chemical reaction Methods 0.000 description 9
229910021529 ammonia Inorganic materials 0.000 description 8
239000000523 sample Substances 0.000 description 8
229910018072 Al 2 O 3 Inorganic materials 0.000 description 6
239000008187 granular material Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
239000000047 product Substances 0.000 description 5
UHSVROPHFKRJIN-UHFFFAOYSA-N 2-methylcyclopentane-1,1-diamine Chemical compound CC1CCCC1(N)N UHSVROPHFKRJIN-UHFFFAOYSA-N 0.000 description 4
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
229910004298 SiO 2 Inorganic materials 0.000 description 4
229910052782 aluminium Inorganic materials 0.000 description 4
229940024548 aluminum oxide Drugs 0.000 description 4
229910002666 PdCl2 Inorganic materials 0.000 description 3
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
230000000694 effects Effects 0.000 description 3
TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
229960005363 aluminium oxide Drugs 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
230000009849 deactivation Effects 0.000 description 2
MIZWKGYFFWJSGO-UHFFFAOYSA-N ethyl carbamate;pyridine Chemical compound CCOC(N)=O.C1=CC=NC=C1 MIZWKGYFFWJSGO-UHFFFAOYSA-N 0.000 description 2
230000002427 irreversible effect Effects 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
229910052759 nickel Inorganic materials 0.000 description 2
238000010992 reflux Methods 0.000 description 2
235000012239 silicon dioxide Nutrition 0.000 description 2
-1 2-Methyl-1,5-diaminopentane urea 3-Methylpiperidine Chemical compound 0.000 description 1
OHRNRQBCDCHNDT-UHFFFAOYSA-N 2-methylpentane-1,5-diamine;3-methylpiperidine Chemical compound CC1CCCNC1.NCC(C)CCCN OHRNRQBCDCHNDT-UHFFFAOYSA-N 0.000 description 1
BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
241000218236 Cannabis Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
208000001840 Dandruff Diseases 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
206010013786 Dry skin Diseases 0.000 description 1
102000010911 Enzyme Precursors Human genes 0.000 description 1
108010062466 Enzyme Precursors Proteins 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
229910052688 Gadolinium Inorganic materials 0.000 description 1
240000005979 Hordeum vulgare Species 0.000 description 1
235000007340 Hordeum vulgare Nutrition 0.000 description 1
241001026509 Kata Species 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
241001676573 Minium Species 0.000 description 1
ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
206010041953 Staring Diseases 0.000 description 1
YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000003513 alkali Substances 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000012159 carrier gas Substances 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
210000004268 dentin Anatomy 0.000 description 1
GGWBHVILAJZWKJ-UHFFFAOYSA-N dimethyl-[[5-[2-[[1-(methylamino)-2-nitroethenyl]amino]ethylsulfanylmethyl]furan-2-yl]methyl]azanium;chloride Chemical compound Cl.[O-][N+](=O)C=C(NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-UHFFFAOYSA-N 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
238000004817 gas chromatography Methods 0.000 description 1
JJQHTLAUSSTREE-UHFFFAOYSA-N hexane-3,3-diamine Chemical compound CCCC(N)(N)CC JJQHTLAUSSTREE-UHFFFAOYSA-N 0.000 description 1
239000012535 impurity Substances 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
238000002078 massotherapy Methods 0.000 description 1
229910000476 molybdenum oxide Inorganic materials 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
PQQKPALAQIIWST-UHFFFAOYSA-N oxomolybdenum Chemical compound [Mo]=O PQQKPALAQIIWST-UHFFFAOYSA-N 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000000843 powder Substances 0.000 description 1
QYPWRPSMKLUGJZ-UHFFFAOYSA-N pyridin-1-ium;sulfate Chemical compound [O-]S([O-])(=O)=O.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 QYPWRPSMKLUGJZ-UHFFFAOYSA-N 0.000 description 1
JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
229910052707 ruthenium Inorganic materials 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
235000014347 soups Nutrition 0.000 description 1
239000000126 substance Substances 0.000 description 1
229910001935 vanadium oxide Inorganic materials 0.000 description 1
101150061972 zur gene Proteins 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/08—Preparation by ring-closure
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
Catalysts (AREA)
Hydrogenated Pyridines (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

LVP-98-124A 1993-04-02 1998-05-28 3-metilpiperidīna un 3-metilpiridīna iegūšanas metode, katalītiski ciklizējot 2-metil-1,5-diaminopentānu LV12129B (lv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH101493		1993-04-02
CH3794A CH686135A5 (de)	1994-01-06	1994-01-06	Verfahren zur Herstellung von 3-Methylpiperidin und 3-Methylpyridin.

Publications (2)

Publication Number	Publication Date
LV12129A LV12129A (lv)	1998-09-20
LV12129B true LV12129B (lv)	1998-12-20

Family

ID=25683321

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-98-124A LV12129B (lv)	1993-04-02	1998-05-28	3-metilpiperidīna un 3-metilpiridīna iegūšanas metode, katalītiski ciklizējot 2-metil-1,5-diaminopentānu

Country Status (27)

Country	Link
US (1)	US5714610A (pl)
EP (1)	EP0691955B1 (pl)
JP (1)	JP3520519B2 (pl)
KR (1)	KR100276748B1 (pl)
AT (1)	ATE153658T1 (pl)
BG (1)	BG62767B1 (pl)
BR (1)	BR9405915A (pl)
CA (1)	CA2159586C (pl)
CZ (1)	CZ287321B6 (pl)
DE (1)	DE59402925D1 (pl)
DK (1)	DK0691955T3 (pl)
EE (1)	EE03176B1 (pl)
ES (1)	ES2104377T3 (pl)
FI (1)	FI112473B (pl)
GE (1)	GEP20012441B (pl)
GR (1)	GR3024294T3 (pl)
HR (1)	HRP940211B1 (pl)
IL (1)	IL109173A (pl)
LV (1)	LV12129B (pl)
NO (1)	NO303937B1 (pl)
PL (1)	PL177347B1 (pl)
RO (2)	RO117914B1 (pl)
RU (1)	RU2127726C1 (pl)
SK (1)	SK281702B6 (pl)
TW (1)	TW239129B (pl)
UA (1)	UA42717C2 (pl)
WO (1)	WO1994022824A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GEP20012441B (en) *	1993-04-02	2001-05-25	Lonza Ag	Process for Preparing 3-Methylpiperidine and 3-Methylpyridine
CH689831A5 (de) *	1995-11-07	1999-12-15	Eprova Ag	Stabile kristalline Tetrahydrofolsaeure-Salze.
ZA968485B (en) *	1995-11-01	1997-05-20	Lonza Ag	Process for preparing nicotinamide
DE10144631A1 (de) *	2001-09-11	2003-03-27	Basf Ag	Verfahren zur Herstellung von Pyrrol und Pyridin
US6995112B2 (en) *	2002-11-08	2006-02-07	Chevron U.S.A. Inc.	Highly homogeneous amorphous silica-alumina catalyst composition
WO2010034616A1 (en) *	2008-09-26	2010-04-01	Dsm Ip Assets B.V.	Method for the preparation of 3-methylpyridine
EP2322273A1 (en) *	2009-10-16	2011-05-18	Lonza Ltd.	Catalysts for the preparation of methylpyridine
US8530664B2 (en)	2009-10-16	2013-09-10	Lonza Ltd.	Catalysts for the preparation of methylpyridine
RU2474473C1 (ru) *	2011-09-16	2013-02-10	Российская Федерация, От Имени Которой Выступает Министерство Промышленности И Торговли Российской Федерации	КАТАЛИЗАТОР, СПОСОБ ЕГО ПРИГОТОВЛЕНИЯ И СПОСОБ ПОЛУЧЕНИЯ β-ПИКОЛИНА
CN103044317B (zh) *	2013-01-07	2015-07-29	清华大学	制备3-甲基吡啶的方法和系统
CN104841475B (zh) *	2014-02-17	2018-09-11	凯赛（金乡）生物材料有限公司	一种用于制备哌啶的改性分子筛催化剂及其制备方法和应用
CN112010802B (zh) *	2020-08-13	2022-03-29	浙江新和成股份有限公司	3-甲基吡啶的连续制备方法
KR20230134699A (ko) *	2022-03-15	2023-09-22	현대자동차주식회사	저온 탈수소화 방법 및 이를 이용하는 수소 발생 시스템

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB755534A (en) *	1953-12-16	1956-08-22	Ici Ltd	Catalytic cyclisation of pentamethylene diamine
FR1115492A (fr) *	1953-12-16	1956-04-25	Ici Ltd	Fabrication de la pipéridine et de la pyridine
US3903079A (en) *	1971-08-27	1975-09-02	Celanese Corp	Production of polymethylenimines by cycloammonolysis
DE2519529B2 (de) *	1975-05-02	1979-08-09	Dynamit Nobel Ag, 5210 Troisdorf	Verfahren zur Herstellung von 3-Methylpyridin
FR2503156A1 (fr) *	1981-04-01	1982-10-08	Rhone Poulenc Spec Chim	Procede de preparation de pyridine et de pyridines substituees
CH654576A5 (en) *	1982-07-29	1986-02-28	Lonza Ag	Process for the preparation of 3-methylpyridine
GB8425969D0 (en) *	1984-10-15	1984-11-21	Ici Plc	Heterocyclic compounds
US5179014A (en) *	1985-01-08	1993-01-12	Nitto Chemical Industry Co., Ltd.	Process for the preparation of amides using microorganisms
JPS61162193A (ja) *	1985-01-08	1986-07-22	Nitto Chem Ind Co Ltd	微生物によるアミド類の製造法
DD274631A5 (de) *	1987-09-18	1989-12-27	Kk	Verfahren zur biologischen herstellung von amiden
US5149816A (en) *	1988-07-11	1992-09-22	Reilly Industries	High temperature process for selective production of 3-methylpyridine
IL90918A (en) *	1988-07-11	1993-05-13	Reilly Ind Inc	Process for selective production of 3-methylpyridine
US5258305A (en) *	1991-09-13	1993-11-02	Nitto Chemical Industry Co., Ltd.	Manufacture of optically active 2-phenylpropionic acid and 2-phenylpropionamide from the nitrile using Rhodococcus equi
GEP20012441B (en) *	1993-04-02	2001-05-25	Lonza Ag	Process for Preparing 3-Methylpiperidine and 3-Methylpyridine
CZ338596A3 (en) *	1994-05-23	1997-07-16	Lonza Ag	Catalytic mixture for oxidative amonolysis of alkyl pyridines, process of its preparation and use

1994
- 1994-03-25 GE GEAP19941824A patent/GEP20012441B/en unknown
- 1994-03-30 RU RU95121817A patent/RU2127726C1/ru active
- 1994-03-30 AT AT94913092T patent/ATE153658T1/de active
- 1994-03-30 CA CA002159586A patent/CA2159586C/en not_active Expired - Lifetime
- 1994-03-30 DK DK94913092.6T patent/DK0691955T3/da not_active Application Discontinuation
- 1994-03-30 CZ CZ19952542A patent/CZ287321B6/cs not_active IP Right Cessation
- 1994-03-30 KR KR1019950704170A patent/KR100276748B1/ko not_active Expired - Lifetime
- 1994-03-30 WO PCT/EP1994/001005 patent/WO1994022824A1/de not_active Ceased
- 1994-03-30 EP EP94913092A patent/EP0691955B1/de not_active Expired - Lifetime
- 1994-03-30 UA UA95094345A patent/UA42717C2/uk unknown
- 1994-03-30 HR HR940211A patent/HRP940211B1/xx not_active IP Right Cessation
- 1994-03-30 RO RO95-01676A patent/RO117914B1/ro unknown
- 1994-03-30 ES ES94913092T patent/ES2104377T3/es not_active Expired - Lifetime
- 1994-03-30 BR BR9405915A patent/BR9405915A/pt not_active IP Right Cessation
- 1994-03-30 DE DE59402925T patent/DE59402925D1/de not_active Expired - Lifetime
- 1994-03-30 RO ROA200201005A patent/RO121267B1/ro unknown
- 1994-03-30 JP JP52167394A patent/JP3520519B2/ja not_active Expired - Fee Related
- 1994-03-30 IL IL10917394A patent/IL109173A/en not_active IP Right Cessation
- 1994-03-30 US US08/525,744 patent/US5714610A/en not_active Expired - Lifetime
- 1994-03-30 SK SK1226-95A patent/SK281702B6/sk not_active IP Right Cessation
- 1994-03-30 PL PL94311006A patent/PL177347B1/pl unknown
- 1994-04-23 TW TW083103633A patent/TW239129B/zh not_active IP Right Cessation
- 1994-06-29 EE EE9400069A patent/EE03176B1/xx not_active IP Right Cessation
1995
- 1995-09-29 NO NO953896A patent/NO303937B1/no not_active IP Right Cessation
- 1995-09-29 FI FI954660A patent/FI112473B/fi not_active IP Right Cessation
- 1995-10-25 BG BG100095A patent/BG62767B1/bg unknown
1997
- 1997-07-30 GR GR970401943T patent/GR3024294T3/el unknown
1998
- 1998-05-28 LV LVP-98-124A patent/LV12129B/lv unknown

Also Published As

Publication number	Publication date
GEP20012441B (en)	2001-05-25
CA2159586C (en)	2003-11-18
CA2159586A1 (en)	1994-10-13
IL109173A (en)	1999-03-12
BG62767B1 (bg)	2000-07-31
CZ287321B6 (en)	2000-10-11
AU678232B2 (en)	1997-05-22
EP0691955A1 (de)	1996-01-17
FI954660A0 (fi)	1995-09-29
ATE153658T1 (de)	1997-06-15
KR100276748B1 (ko)	2001-01-15
UA42717C2 (uk)	2001-11-15
JPH08510447A (ja)	1996-11-05
KR960701014A (ko)	1996-02-24
GR3024294T3 (en)	1997-10-31
NO303937B1 (no)	1998-09-28
HRP940211A2 (en)	1997-06-30
FI954660L (fi)	1995-09-29
SK281702B6 (sk)	2001-07-10
NO953896D0 (no)	1995-09-29
BR9405915A (pt)	1995-12-12
AU6537694A (en)	1994-10-24
JP3520519B2 (ja)	2004-04-19
NO953896L (no)	1995-09-29
HRP940211B1 (en)	2000-06-30
RO117914B1 (ro)	2002-09-30
RO121267B1 (ro)	2007-02-28
DE59402925D1 (de)	1997-07-03
FI112473B (fi)	2003-12-15
EP0691955B1 (de)	1997-05-28
LV12129A (lv)	1998-09-20
TW239129B (pl)	1995-01-21
EE03176B1 (et)	1999-04-15
DK0691955T3 (da)	1997-06-16
ES2104377T3 (es)	1997-10-01
PL177347B1 (pl)	1999-10-29
WO1994022824A1 (de)	1994-10-13
PL311006A1 (en)	1996-01-22
IL109173A0 (en)	1994-06-24
US5714610A (en)	1998-02-03
BG100095A (bg)	1996-05-31
CZ254295A3 (en)	1996-03-13
SK122695A3 (en)	1996-02-07
RU2127726C1 (ru)	1999-03-20

Publication	Publication Date	Title
LV12129B (lv)	1998-12-20	3-metilpiperidīna un 3-metilpiridīna iegūšanas metode, katalītiski ciklizējot 2-metil-1,5-diaminopentānu
EP0770687B1 (de)	2002-01-23	Verfahren zur Herstellung von Nikotinsäureamid
RU96121285A (ru)	1998-12-27	Способ получения амида никотиновой кислоты
CH667455A5 (de)	1988-10-14	Konversion einer mischung aus 3-methylpyridin und 3-methylpiperidin zu 3-cyanopyridin.
EP0263464A2 (de)	1988-04-13	Verfahren zur Herstellung von substituierten Pyridinen
DE2537837A1 (de)	1976-03-18	Tetrahydropyridin- und piperidinderivate und verfahren zu ihrer herstellung
US5218122A (en)	1993-06-08	Pyridine base synthesis process and catalyst for same
DE2438399C3 (de)	1979-06-13	a-substituierte Benzhydrolderivate und ihre Salze, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
CH631705A5 (de)	1982-08-31	Verfahren zur herstellung substituierter pyridine.
DE69619821T2 (de)	2002-11-28	Pyridinbasen-synthese
DE2951247C2 (pl)	1988-03-10
EP0552130B1 (de)	1996-03-20	Verfahren zur Herstellung von Nitrobenzol
DE68924852T2 (de)	1996-03-21	Verfahren zur herstellung von pyridinbasen und katalysator zur durchführung des verfahrens.
EP0318845B1 (de)	1992-09-16	Verfahren zur Herstellung von substituierten Pyridinen
DE2601923A1 (de)	1976-07-22	Phenylalkylamine
DE69606305T2 (de)	2000-08-10	Katalyst, herstellungsverfahren und verwendung in einem verfahren zur herstellung von metyhlaminen
GB1561013A (en)	1980-02-13	Catecholamine derivatives
DE2653147C2 (pl)	1991-09-19
DE19524240A1 (de)	1997-01-09	Verfahren zur Herstellung von Aminen aus Gemischen, die man bei der Spaltung von Erdölfraktionen erhält, an Zeolithen, Alumosilikaten oder hydrothermal hergestellten Phosphaten
Singh et al.	1969	Antimalarials. 4-Proximal hydrazino derivatives of 7-chloroquinoline
DE60100044T2 (de)	2003-07-24	Verfahren zur Herstellung von Isoindolin
CH686135A5 (de)	1996-01-15	Verfahren zur Herstellung von 3-Methylpiperidin und 3-Methylpyridin.
DE3123942C2 (de)	1986-08-28	4-Methoxy-N-[2-[2-(1-methyl-2-piperidyl-1-oxid)ethyl]-phenyl]benzamid, Verfahren zur Herstellung dieser Verbindung und diese Verbindung enthaltendes pharmazeutisches Mittel
DE4137013A1 (de)	1993-05-13	Verfahren zur herstellung von aminen durch reduktive aminierung
DE1670844C3 (de)	1974-06-06	Arylsulfonylharnstoffe und Verfahren zu ihrer Herstellung